Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Newron Pharmaceuticals SpA
Newron presents H1 2026 results and provides corporate update
September 22, 2026
Newron Secures EUR 5.5M Financing for Evenamide Phase 3 Program
September 8, 2026
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
September 2, 2026